Therapeutics

By Myra Myrna 6 years ago

ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for

By Myra Myrna 6 years ago

WOBURN, Mass.–(Enterprise WIRE)–Mar 29, 2021– Frequency Therapeutics, Inc. (Nasdaq: FREQ), a medical-stage biotechnology organization concentrated

By Myra Myrna 6 years ago

– Advanced ALG-010133 and ALG-000184 into the clinic – both expected to generate safety and

By Myra Myrna 6 years ago

The MarketWatch News Department was not involved in the creation of this content. Vancouver, British

By Myra Myrna 6 years ago

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing

By Myra Myrna 6 years ago

News Highlights Libervant™ (diazepam) Buccal Film New Drug Application (NDA) resubmission expected end of second

By Myra Myrna 6 years ago

Libervant™ (diazepam) Buccal Film New Drug Application (NDA) resubmission expected end of second quarter 2021

By Myra Myrna 6 years ago

Sale of Manufacturing Operations to Catalent with net proceeds of ~$74 million Annual operating expenses

By Myra Myrna 6 years ago

BRIDGEWATER, N.J., March 04, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or

By Myra Myrna 6 years ago

Acorda Therapeutics Announces Departure of Chief, Enterprise Functions Acorda Therapeutics, Inc. (Nasdaq: ACOR) today declared

By Myra Myrna 6 years ago

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that David Lawrence, Main, Small business Operations and its